Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE2708.75108.6 (+4.18 %)
PREV CLOSE () 2600.15
OPEN PRICE () 2634.75
BID PRICE (QTY) 2706.00 (20)
OFFER PRICE (QTY) 2708.75 (18)
VOLUME 12270
TODAY'S LOW / HIGH ()2601.65 2753.95
52 WK LOW / HIGH ()1910.1 3050
NSE2716.85116.45 (+4.48 %)
PREV CLOSE() 2600.40
OPEN PRICE () 2620.00
BID PRICE (QTY) 2716.15 (14)
OFFER PRICE (QTY) 2717.80 (21)
VOLUME 642470
TODAY'S LOW / HIGH() 2602.60 2754.70
52 WK LOW / HIGH ()1901.05 3054.8
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1991

Management Info :

Ramesh Juneja - Chairman Rajeev Juneja - Managing Director

Registered Office :

Address : 208,Okhla Industrial Estate,Phase - 111,
New Delhi,
Delhi-110020

Phone : 011-46846700

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
15Jan Mankind Pharma informs about update
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Ob..
27Dec Mankind Pharma, Innovent Biologics par
Mankind Pharma and Innovent Biologics have partnered to exclusively lice..
20Dec Mankind Pharma informs about updates
Mankind Pharma has informed that the Fund Raising Committee of Directors..
03Dec Appointment of Director
Interalia, considered and approved the following: 1. the disposal of th..
15Nov Mankind Pharma informs about disclosu
Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regul..
Financials
in Millions
QTR Sep 24 ANNUAL 24
Net Profit6344.318234.11
Gross Profit 7704.5 22595.68
Operating Profit 8577.925917.44
Net Sales 25297.492648.09
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 13828.20 (1.29%)
M.Cap ( in Cr)
17707.30
Divi's Lab (BSE)
 6014.05 (1.69%)
M.Cap ( in Cr)
159014.35
Glaxosmithkline Phar (BSE)
 2137.50 (3.65%)
M.Cap ( in Cr)
36125.84
Procter&Gamble Healt (BSE)
 5474.10 (1.29%)
M.Cap ( in Cr)
9086.67
RPG Life Sciences (BSE)
 2145.25 (3.16%)
M.Cap ( in Cr)
3548.03
Shareholding Pattern
PROMOTERS 72.71%
MUTUAL FUNDS/UTI 7.83%
NON-INSTITUTION 2.9%
FI/BANKS/INSURANCE 2.21%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX77162.07542.74 (0.71%)
NIFTY23361.90158.70 (0.68%)
Dow Jones 43487.83334.70 (0.78%)
Nasdaq 19630.20291.91 (1.51%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI